Mehmet B Yilmaz Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

6/2015

Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mehmet B Yilmaz Research Topics

Disease

13	Heart Failure 09/2023 - 12/2013
4	Atrial Fibrillation 01/2022 - 09/2004
2	Heart Diseases (Heart Disease) 01/2022 - 01/2018
2	Myocardial Infarction 01/2022 - 01/2022
2	Body Weight (Weight, Body) 01/2019 - 05/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Sudden Death 12/2021
1	Systolic Heart Failure 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Chest Pain (Chest Pains) 01/2020
1	Acute Coronary Syndrome 01/2020
1	Dyspnea (Shortness of Breath) 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2018
1	Atherosclerosis 04/2018
1	Sepsis (Septicemia) 12/2013
1	Melanoma (Melanoma, Malignant) 10/2008
1	Atrial Heart Septal Defects (Atrial Septal Defect) 09/2004

Drug/Important Bio-Agent (IBA)

6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2018
5	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2021 - 01/2016
4	omecamtiv mecarbilIBA 09/2023 - 11/2020
4	Natriuretic PeptidesIBA 01/2022 - 01/2019
3	Cardiac MyosinsIBA 01/2022 - 11/2020
3	Neprilysin (Neutral Endopeptidase)IBA 12/2021 - 01/2018
3	Valsartan (Vals)FDA Link 12/2021 - 01/2018
3	paragonIBA 12/2021 - 01/2018
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2020
2	Angiotensin Receptor AntagonistsIBA 12/2021 - 01/2018
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2021 - 01/2018
2	DiureticsIBA 01/2021 - 01/2018
2	Simendan (Levosimendan)IBA 11/2019 - 12/2013
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	UlaritideIBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 05/2018
1	Blood Glucose (Blood Sugar)IBA 05/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2018
1	apelin-13 peptideIBA 04/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2015
1	Potassium Channels (Potassium Channel)IBA 12/2013
1	CalciumIBA 12/2013
1	Muramidase (Lysozyme)IBA 10/2008
1	Atrial Natriuretic Factor (ANF)IBA 09/2004

Therapy/Procedure

5	Therapeutics 01/2021 - 11/2019
1	Length of Stay 01/2019
1	Intravenous Infusions 01/2019
1	Patient Readmission 01/2019
1	Renal Dialysis (Hemodialysis) 04/2018